Publication: Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus
| dc.contributor.author | Yingyongnarongkul B.-E. | |
| dc.contributor.author | Apiratikul N. | |
| dc.contributor.author | Aroonrerk N. | |
| dc.contributor.author | Suksamrarn A. | |
| dc.date.accessioned | 2021-04-05T04:32:17Z | |
| dc.date.available | 2021-04-05T04:32:17Z | |
| dc.date.issued | 2006 | |
| dc.date.issuedBE | 2549 | |
| dc.description.abstract | A library of hydroxycinnamic acid amides (HCAAs) and analogues were synthesized using solid-phase synthesis technique. These compounds were screened for antibacterial against methicillin-resistant Staphylococcus aureus (MRSA) (11 strains) and vancomycin-resistant S. aureus (VRSA) (4 strains). Dihydrocaffeoyl analogues showed activity against VRSA which were better than the reference drugs, vancomycin and oxacillin. These compounds also exhibited antibacterial activity against MRSA, which were more potent than oxacillin. © 2006 Elsevier Ltd. All rights reserved. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Bioorganic and Medicinal Chemistry Letters. Vol 16, No.22 (2006), p.5870-5873 | |
| dc.identifier.doi | 10.1016/j.bmcl.2006.08.062 | |
| dc.identifier.issn | 0960894X | |
| dc.identifier.other | 2-s2.0-33749434812 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/5309 | |
| dc.rights.holder | Scopus | |
| dc.subject.other | Hydrocinnamic acid derivative | |
| dc.subject.other | Meticillin | |
| dc.subject.other | Oxacillin | |
| dc.subject.other | Vancomycin | |
| dc.subject.other | Antibacterial activity | |
| dc.subject.other | Antibiotic resistance | |
| dc.subject.other | Article | |
| dc.subject.other | Bacterial strain | |
| dc.subject.other | Controlled study | |
| dc.subject.other | Drug potency | |
| dc.subject.other | Drug screening | |
| dc.subject.other | Drug synthesis | |
| dc.subject.other | Methicillin resistant Staphylococcus aureus | |
| dc.subject.other | Minimum inhibitory concentration | |
| dc.subject.other | Nonhuman | |
| dc.subject.other | Solid phase synthesis | |
| dc.subject.other | Staphylococcus aureus | |
| dc.subject.other | Amides | |
| dc.subject.other | Anti-Bacterial Agents | |
| dc.subject.other | Caffeine | |
| dc.subject.other | Combinatorial Chemistry Techniques | |
| dc.subject.other | Coumaric Acids | |
| dc.subject.other | Drug Combinations | |
| dc.subject.other | Ethanol | |
| dc.subject.other | Methicillin Resistance | |
| dc.subject.other | Oxacillin | |
| dc.subject.other | Staphylococcus aureus | |
| dc.subject.other | Vancomycin Resistance | |
| dc.subject.other | Methicillin resistant Staphylococcus aureus | |
| dc.subject.other | Staphylococcus aureus | |
| dc.title | Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749434812&doi=10.1016%2fj.bmcl.2006.08.062&partnerID=40&md5=39c9287b3f1fcba02da89c016669696b |
